Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

SRx Health Solutions (SRXH) Shares Outstanding (Diluted Average) (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Shares Outstanding (Diluted Average) for 14 consecutive years, with $21.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Diluted Average) fell 4.4% year-over-year to $21.1 million, compared with a TTM value of $21.1 million through Sep 2025, down 4.4%, and an annual FY2025 reading of $21.1 million, changed N/A over the prior year.
  • Shares Outstanding (Diluted Average) was $21.1 million for Q3 2025 at SRx Health Solutions, up from $20.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $29.5 million in Q3 2021 and bottomed at $667114.0 in Q4 2022.
  • Average Shares Outstanding (Diluted Average) over 5 years is $15.1 million, with a median of $21.1 million recorded in 2025.
  • The sharpest move saw Shares Outstanding (Diluted Average) crashed 97.64% in 2023, then soared 3244.19% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $21.9 million in 2021, then crashed by 96.95% to $667114.0 in 2022, then increased by 5.71% to $705185.0 in 2023, then skyrocketed by 3244.19% to $23.6 million in 2024, then fell by 10.5% to $21.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for SRXH at $21.1 million in Q3 2025, $20.4 million in Q2 2025, and $2.6 million in Q1 2025.